Albert Liu, MD MPH

Dr. Albert Liu is the Clinical Research Director at Bridge HIV. Over the past two decades, he has conducted research on the safety and effectiveness of PrEP, strategies to monitor and support PrEP adherence, and how to best implement PrEP in real-world settings. He has served as an investigator of several trials of novel HIV preventive agents and formulations within the HIV Prevention Trials Network and the Microbicide Trials Network. He also served as protocol chair of the US PrEP Demo Project and a PrEP demonstration project among transgender populations in the San Francisco Bay Area. He is co-chair of the PrEP Committee of the San Francisco Getting to Zero Consortium. Additionally, he is an attending physician at the Zuckerberg San Francisco General Hospital and serves as a member of the UCSF Institutional Review Board.

photo © Reuters / Kimberly White